Fitness Ozempic, Wegovy: India’s cheap weight-loss drugs could reshape global obesity fight Published 1 month ago on March 18, 2026 By News24x7 Share Tweet With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market. Related Topics: Up Next ‘Club vibes without the hangover’: The twenty-somethings going out – in the gym Don't Miss Jersey woman felt ‘responsibility’ to share diabetes diagnosis Continue Reading Latest Sports13 minutes ago European Challenge Cup: Dragons flying flag for Wales against Montpellier Sports21 minutes ago Joe Allen: Swansea City leave door open for departing coach as Leon Britton and Kristian O’Leary stay on Bussiness35 minutes ago No evidence of widespread fuel price-gouging, says watchdog Travel36 minutes ago EasyJet launches ‘book with confidence’ pledge as specialists promise no surcharges Bussiness46 minutes ago ‘We’re in a successful band but still work jobs’ Travel58 minutes ago Jet fuel crunch threatens European air travel World1 hour ago Israel releases all but two activists in Greece after intercepting Gaza aid flotilla Travel1 hour ago Jet2 gears up for its busiest May Day bank holiday weekend Sports1 hour ago Fury vs Joshua: Pop star Dua Lipa not expected to perform at event Horoscope1 hour ago Your May Horoscope